Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

NCT00240344 · clinicaltrials.gov ↗
COMPLETED
Status
2650
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca